Graphene nanoflakes can deliver drugs to target tissues
Phys.org - 19-Aug-2019Tested on mice model - need to slow down excretion from tissues
Join the club for FREE to access the whole archive and other member benefits.
Principal Investigator at University of Zurich.
Jason is
from Yorkshire in the United Kingdom and received a master’s degree in
Chemistry from the University of York (MChem, 2004) followed by a
doctorate from the University of Oxford (D.Phil, 2008). He trained as
post-doctoral scholar with Jason S. Lewis in radiochemistry and
translational molecular imaging at Memorial Sloan-Kettering Cancer
Center in New York (2008 – 2010). He was then awarded an ETH Fellowship
and worked at ETH Zürich and the Paul Scherrer Institute (2010 –
2012). Following this he was appointed as Assistant in Chemistry in the
Division of Nuclear Medicine and Molecular Imaging at Massachusetts
General Hospital, Boston, with a joint faculty appointment as an
Instructor in Radiology at Harvard Medical School (2012 – 2014). In
2015, he worked in the Department of Nuclear Medicine at the University
Hospital Freiburg as a Visiting Scientist. In April 2016, Jason began
his research group as an SNSF Professor in the Department of Chemistry
at the University of Zurich, funded by the European Research Council,
the Swiss National Science Foundation and the University of Zurich.
Research activities focus on advancing radiochemical methods with
various radionuclides (18F, 64Cu, 68Ga, 90Y, 89Zr, 111In, 177Lu etc),
and developing molecular imaging agents that target oncogenic signalling
pathways in cancer.
Visit website: https://www.hollandlab.org/group
See also: University of Zurich - Public Research university.
Details last updated 21-Nov-2019
Tested on mice model - need to slow down excretion from tissues